Premium Information is available for this item - Upgrade for $1 a day
6505-00-913-0853
Usp Hydroxyzine Hydrochloride Tablets
6505009130853 009130853 ATARAX NDC00049-5620-66 3927
INC: 34188 Hydroxyzine Hydrochloride Tablets
January 2023
5
Marketplace 6505-00-913-0853
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-913-0853 5+ Documents (More...)
RQST NE Updated Every Day 6505-00-913-0853 RQST Updated Every Day 6505-00-913-0853 RQST NE Related
Documents 6505-00-913-0853 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505
Usp Hydroxyzine Hydrochloride Tablets 270-8796 https -65/fsc-6505/us 6505-00-913-0853 https//www.nsnlookup.com
Hydrochloride Tablets Documents 6505-01-387-5965 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-913-0853
568-9581 6505-01-116-0731 6505-01-387-5965 6505-01-270-8796 6505-33-189-8673 6505-01-114-8657 6505-00-913-0853
Usp Hydroxyzine Hydrochloride Tablets 189-8673 6505-01-114-8657 6505-00-913-0853 https https//www.nsnlookup.com
Usp Hydroxyzine Hydrochloride Tablets www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-365-7177 https 009130853
Tablets your Account Upgrade 6505-00-913-0853Usp Hydroxyzine Hydrochloride Tablets6505009130853 009130853
ATARAX Tablets your Account Upgrade 6505-01-114-8657Usp Hydroxyzine Hydrochloride Tablets6505011148657
Restrictions 6505-00-913-0853
6505-00-913-0853 is a Usp Hydroxyzine Hydrochloride Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-00-913-0853
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-913-0853
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-913-0853
- Part Number
- Manufacturer
- Status
- NDC00049-5620-66
- Manufacturer
- 04517 - Roerig Div Pfizer Inc (Active)
- Primary Buy
- Primary Buy
- 3927
- 04517 - Roerig Div Pfizer Inc (Active)
- Primary Buy
- Primary Buy
- ATARAX
- 04517 - Roerig Div Pfizer Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-913-0853
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Hydroxyzine Hydrochloride Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
Similar Supply Items to 6505-00-913-0853
Freight Information 6505-00-913-0853
6505-00-913-0853 has freight characteristics.. 6505-00-913-0853 has a variance between NMFC and UFC when transported by rail and the description should be consulted.